Amgen Inc (AMGN)
283.61
-12.32
(-4.16%)
USD |
NASDAQ |
Nov 15, 16:00
283.55
-0.06
(-0.02%)
After-Hours: 20:00
Amgen Shares Outstanding: 537.53M for Oct. 25, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 25, 2024 | 537.53M |
September 30, 2024 | 537.50M |
August 01, 2024 | 537.33M |
June 30, 2024 | 537.00M |
April 29, 2024 | 536.43M |
April 01, 2024 | 536.38M |
March 31, 2024 | 535.92M |
February 09, 2024 | 535.92M |
December 31, 2023 | 535.40M |
October 26, 2023 | 535.18M |
September 30, 2023 | 535.10M |
July 31, 2023 | 534.90M |
June 30, 2023 | 534.90M |
April 24, 2023 | 534.33M |
March 31, 2023 | 534.30M |
March 20, 2023 | 534.22M |
February 06, 2023 | 533.98M |
December 31, 2022 | 534.00M |
October 31, 2022 | 533.58M |
September 30, 2022 | 533.50M |
August 01, 2022 | 534.93M |
June 30, 2022 | 534.90M |
April 22, 2022 | 534.20M |
March 31, 2022 | 534.20M |
March 18, 2022 | 533.78M |
Date | Value |
---|---|
February 25, 2022 | 533.77M |
February 11, 2022 | 557.03M |
December 31, 2021 | 558.30M |
October 28, 2021 | 563.27M |
September 30, 2021 | 565.00M |
July 29, 2021 | 567.85M |
June 30, 2021 | 569.60M |
April 22, 2021 | 574.55M |
March 31, 2021 | 575.30M |
March 19, 2021 | 575.80M |
February 03, 2021 | 577.57M |
December 31, 2020 | 578.30M |
October 23, 2020 | 582.17M |
September 30, 2020 | 583.50M |
July 23, 2020 | 585.69M |
June 30, 2020 | 586.40M |
April 27, 2020 | 588.25M |
March 31, 2020 | 588.00M |
March 20, 2020 | 587.76M |
February 06, 2020 | 589.81M |
December 31, 2019 | 591.40M |
October 23, 2019 | 594.18M |
September 30, 2019 | 596.20M |
July 24, 2019 | 599.70M |
June 30, 2019 | 602.10M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
533.50M
Minimum
Sep 30 2022
591.40M
Maximum
Dec 31 2019
553.45M
Average
537.16M
Median
Shares Outstanding Benchmarks
Johnson & Johnson | 2.408B |
Eli Lilly and Co | 949.32M |
Merck & Co Inc | 2.530B |
Regeneron Pharmaceuticals Inc | 109.89M |
Viking Therapeutics Inc | 111.44M |